C122H135F4N29O6 — CID 158620752
[6-[6-(cyclohexylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;3-[[(1S,2R)-2-(4-fluoro-3-methylphenyl)cyclopropyl]methyl]-6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazine;(2S)-2-[[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]amino]-2-(4-methylphenyl)ethanol;methane;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-(4-methylphenyl)propyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-[4-methyl-2-(trifluoromethyl)phenyl]ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol (PubChem CID 158620752) has the molecular formula C122H135F4N29O6 and a molecular weight of 2179.61 g/mol. Its IUPAC name is [6-[6-(cyclohexylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;3-[[(1S,2R)-2-(4-fluoro-3-methylphenyl)cyclopropyl]methyl]-6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazine;(2S)-2-[[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]amino]-2-(4-methylphenyl)ethanol;methane;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-(4-methylphenyl)propyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-[4-methyl-2-(trifluoromethyl)phenyl]ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol.
| Compound Name | [6-[6-(cyclohexylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;3-[[(1S,2R)-2-(4-fluoro-3-methylphenyl)cyclopropyl]methyl]-6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazine;(2S)-2-[[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]amino]-2-(4-methylphenyl)ethanol;methane;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-(4-methylphenyl)propyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-[4-methyl-2-(trifluoromethyl)phenyl]ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol |
|---|---|
| PubChem CID | 158620752 |
| Molecular Formula | C122H135F4N29O6 |
| Molecular Weight | 2179.61 g/mol |
| Exact Mass | 2178.11 |
| IUPAC Name | [6-[6-(cyclohexylamino)-5-methylpyridazin-3-yl]-3-(4-methylimidazol-1-yl)-2-pyridinyl]methanol;3-[[(1S,2R)-2-(4-fluoro-3-methylphenyl)cyclopropyl]methyl]-6-[6-methoxy-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazine;(2S)-2-[[6-[6-(hydroxymethyl)-5-(4-methylimidazol-1-yl)-2-pyridinyl]-4-methylpyridazin-3-yl]amino]-2-(4-methylphenyl)ethanol;methane;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-(4-methylphenyl)propyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol;[3-(4-methylimidazol-1-yl)-6-[5-methyl-6-[[(1S)-1-[4-methyl-2-(trifluoromethyl)phenyl]ethyl]amino]pyridazin-3-yl]-2-pyridinyl]methanol |
| SMILES | C.CC[C@H](Nc1nnc(-c2ccc(-n3cnc(C)c3)c(CO)n2)cc1C)c1ccc(C)cc1.COc1nc(-c2cc(C)c(C[C@@H]3C[C@H]3c3ccc(F)c(C)c3)nn2)ccc1-n1cnc(C)c1.Cc1ccc([C@@H](CO)Nc2nnc(-c3ccc(-n4cnc(C)c4)c(CO)n3)cc2C)cc1.Cc1ccc([C@H](C)Nc2nnc(-c3ccc(-n4cnc(C)c4)c(CO)n3)cc2C)c(C(F)(F)F)c1.Cc1cn(-c2ccc(-c3cc(C)c(NC4CCCCC4)nn3)nc2CO)cn1 |
| InChI | InChI=1S/C26H26FN5O.C25H25F3N6O.C25H28N6O.C24H26N6O2.C21H26N6O.CH4/c1-15-9-18(5-6-21(15)27)20-11-19(20)12-23-16(2)10-24(31-30-23)22-7-8-25(26(29-22)33-4)32-13-17(3)28-14-32;1-14-5-6-18(19(9-14)25(26,27)28)17(4)30-24-15(2)10-21(32-33-24)20-7-8-23(22(12-35)31-20)34-11-16(3)29-13-34;1-5-20(19-8-6-16(2)7-9-19)28-25-17(3)12-22(29-30-25)21-10-11-24(23(14-32)27-21)31-13-18(4)26-15-31;1-15-4-6-18(7-5-15)21(12-31)27-24-16(2)10-20(28-29-24)19-8-9-23(22(13-32)26-19)30-11-17(3)25-14-30;1-14-10-18(25-26-21(14)23-16-6-4-3-5-7-16)17-8-9-20(19(12-28)24-17)27-11-15(2)22-13-27;/h5-10,13-14,19-20H,11-12H2,1-4H3;5-11,13,17,35H,12H2,1-4H3,(H,30,33);6-13,15,20,32H,5,14H2,1-4H3,(H,28,30);4-11,14,21,31-32H,12-13H2,1-3H3,(H,27,29);8-11,13,16,28H,3-7,12H2,1-2H3,(H,23,26);1H4/t19-,20-;17-;20-;21-;;/m0001../s1 |
| InChIKey | HXYQAPFJRLGHNL-CXLHCPACSA-N |
| XLogP | 22.68 |
| TPSA | 440.95 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 31 |
| Heavy Atoms | 161 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2179.61 |
| LogP ≤ 5 | 22.68 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 35 |